Biotech Outlook 2022: Ample Opportunity for a Rebound

By
Published 0, 0000 | 15 min listen

After an historic run in 2020, the biotech sector had a difficult year with slower activity in 2021. The pendulum, however, may be ready to swing back the other way.

Biopharma